Early research (Phase 1)Study completedNCT02388009What this trial is testingSafety and Tolerability of a Bioconjugate Vaccine Against Shigella Flexneri 2aWho this might be right forShigellosis LimmaTech Biologics AG 30
Early research (Phase 1)Study completedNCT01336699What this trial is testingSafety and Immunogenicity of Two Live, Attenuated Oral Shigella Sonnei Vaccines: WRSs2 and WRSs3Who this might be right forShigella Infection National Institute of Allergy and Infectious Diseases (NIAID) 89
Early research (Phase 1)Study completedNCT01069471What this trial is testingSafety and Reactogenicity of Bioconjugate Vaccine to Prevent ShigellaWho this might be right forShigellosis GlycoVaxyn AG 40
Early research (Phase 1)Study completedNCT05987488What this trial is testingShigETEC Vaccine Study in BangladeshWho this might be right forHealthy Volunteers Eveliqure Biotechnologies GmbH 196
Not applicableStudy completedNCT02516683What this trial is testingThe Long Term Clinical Course of Postinfectious Irritable Bowel Syndrome After Shigellosis; A 10 Year Follow up StudyWho this might be right forShigella Sonnei Infection Yonsei University 229
Testing effectiveness (Phase 2)Study completedNCT04242264What this trial is testingPhase 2 Shigella Vaccine and ChallengeWho this might be right forImmunisationShigella Infection National Institute of Allergy and Infectious Diseases (NIAID) 69
Not applicableUnknownNCT04694235What this trial is testingEgg Intervention During Pregnancy in IndonesiaWho this might be right forWeight GainAnemia, Iron DeficiencyBirth Weight+14 more SEAMEO Regional Centre for Food and Nutrition 702
Testing effectiveness (Phase 2)Study completedNCT05121974What this trial is testingTebipenem Trial in Children With ShigellosisWho this might be right forShigellosis International Centre for Diarrhoeal Disease Research, Bangladesh 132
Large-scale testing (Phase 3)Study completedNCT00321126What this trial is testingZinc Supplementation in Shigella PatientsWho this might be right forTesting Effect of Intervention International Centre for Diarrhoeal Disease Research, Bangladesh 56
Testing effectiveness (Phase 2)Looking for participantsNCT07433426What this trial is testingThe Impact of Shigellosis and Recommended Treatment in ChildrenWho this might be right forDiarrhea InfectiousShigellaGrowth & Development Johns Hopkins Bloomberg School of Public Health 700
Early research (Phase 1)Study completedNCT02934178What this trial is testingShigella WRSS1 Vaccine Trial in BangladeshWho this might be right forDiarrhea PATH 16
Not applicableActive Not RecruitingNCT06047821What this trial is testingEnterics for Global Health (EFGH)Who this might be right forShigellaChildDiarrhea University of Washington 9,800
Testing effectiveness (Phase 2)Study completedNCT03527173What this trial is testingEvaluate the Efficacy, Safety and Immunogenicity of a Vaccine Designed to Protect Against Infection With Shigella Sonnei in Healthy AdultsWho this might be right forDysentery, Bacillary GlaxoSmithKline 71
Testing effectiveness (Phase 2)Study completedNCT06523231What this trial is testingStudy to Expand Safety and Immunogenicity Data With Shigella Bioconjugate Vaccine (Shigella4V2) in 9-month-old Infants.Who this might be right forShigellosis LimmaTech Biologics AG 110
Early research (Phase 1)Study completedNCT03561181What this trial is testingSafety Study of S.Flexneriza-S.Sonnei Bivalent Conjugate Vaccine in Healthy Volunteers Aged Above 3 MonthsWho this might be right forDysenteryDysentery, Bacillary Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd 180
Early research (Phase 1)Study completedNCT02445963What this trial is testingSafety and Immunogenicity of Artificial Invaplex (Shigella Flexneri 2a InvaplexAR)Who this might be right forShigellosisBacillary Dysentery U.S. Army Medical Research and Development Command 38
Early research (Phase 1)Study completedNCT02531685What this trial is testingPhase 1 Study of dmLT ID Vaccination in Healthy AdultsWho this might be right forGastroenteritis Escherichia Coli National Institute of Allergy and Infectious Diseases (NIAID) 100
Early research (Phase 1)Study completedNCT00082069What this trial is testingInvaplex 50 Vaccine Dose-RangingWho this might be right forDiarrhea U.S. Army Medical Research and Development Command 32
Testing effectiveness (Phase 2)Study completedNCT00800930What this trial is testingTherapeutic Induction of Endogenous AntibioticsWho this might be right forShigellosis International Centre for Diarrhoeal Disease Research, Bangladesh 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07666750What this trial is testingSafety and Immunogenicity Study of IP-QSV Vaccine in Healthy Adults/Adolescents, Children and InfantsWho this might be right forShigella Infection International Vaccine Institute 370